Rentokil Initial PLC Net Income

RTO Stock  USD 32.34  -0.25  -0.77%   
According to momentum metrics, Rentokil Initial reflects the relative strength indicator of 0, indicating compressed downside momentum. At these depths, Rentokil Initial may be approaching exhaustion on the sell side, though timing a reversal requires additional confirmation.
Momentum
Sell Peaked
 
Oversold
 
Overbought
As of the 14th of March 2026, Rentokil Initial is marked at 32.34 per share. Recent trend indicators show Coefficient Of Variation of 1018.82, risk adjusted performance of 0.0845, and Semi Deviation of 1.87. Trend analytics rely on normalized volatility and volume metrics. Trend metrics are reviewed within historical sector ranges.
Total Revenue is evolving in line with broader financial reporting trends. Last year, Rentokil Initial recorded Total Revenue of 5.14 Billion. Operating Profit Margin is evolving in line with broader financial reporting trends. Last year, Rentokil Initial recorded Operating Profit Margin of 0.14. Per market data dated March 14, 2026, Net Profit Margin is projected to grow to 0.11, whereas our analysis places Gross Profit near about 667.8 M following downward revisions.

Rentokil Initial Total Revenue

5.4 Billion
Year-over-year changes in Rentokil Initial's income statement and balance sheet highlight where the business is improving or deteriorating. Key fundamentals are shown below:
 Gross Profit
658 M
 Profit Margin
0.068
 Market Capitalization
16.6 B
 Enterprise Value Revenue
2.9465
 Revenue
6.9 B
Rentokil Initial PLC presents one hundred twenty measurable fundamental measures spanning income, balance sheet, and cash flow categories. Long-term investors should confirm how Rentokil Initial's latest metrics compare to the historical baseline from 2010 to 2026 before making allocation decisions. Per market data dated March 14, 2026, Market Cap is projected to contract toward approximately 1.9 B. In addition to that, Enterprise Value is projected to contract toward approximately 2.9 B Cross-market screening tools are available via Equity Screeners for extended research.
Last ReportedProjected for Next Year
Net Income215.7 M263.9 M
Net Income Applicable To Common Shares353.1 M294 M
Net Income From Continuing Ops353.1 M244.4 M
Net Income Per Share 0.14 0.07
Net Income Per E B T 1.21 0.66
Per market data dated March 14, 2026, Net Income is projected to grow to approximately 263.9 M, whereas our analysis places Net Income Applicable To Common Shares near about 294 M following downward revisions..
  
Build AI portfolio with Rentokil Stock
Evaluating Rentokil Initial's Net Income across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Rentokil Initial PLC's fundamental strength.

Latest Rentokil Initial's Net Income Growth Pattern

Below is the plot of the Net Income of Rentokil Initial PLC over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Rentokil Initial PLC financial statement analysis. It represents the amount of money remaining after all of Rentokil Initial PLC operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Rentokil Initial's Net Income historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Rentokil Initial's overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported 215.73 M10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Rentokil Net Income Regression Statistics

Arithmetic Mean 190,353,815
Geometric Mean 146,750,386
Coefficient Of Variation 99.03
Mean Deviation 138,536,510
Median 186,000,000
Standard Deviation 188,509,073
Sample Variance35535.7T
Range781.1M
R-Value 0.54
Mean Square Error26953.1T
R-Squared 0.29
Significance 0.03
Slope 20,065,697
Total Sum of Squares568570.7T

Rentokil Net Income History

2026201.2 M
2025349.6 M
2024307 M
2023381 M
2022232 M
2021263 M
2020186 M

Other Fundumenentals of Rentokil Initial PLC

Rentokil Initial Net Income component correlations

Rentokil Net Income Driver Correlations

Sound financial modeling for Rentokil Initial requires a clear understanding of how Rentokil Initial's accounts, including Net Income, are correlated. Because Rentokil Initial's income statement, balance sheet, and cash flow items are all interconnected, a correlation-based approach to analysis is more effective than examining each statement independently.
 Quarterly Earnings Growth
0.883
 Dividend Share
0.124
 Earnings Share
0.57
 Revenue Per Share
13.685
 Quarterly Revenue Growth
-0.04
Market capitalization and book value offer complementary views of Rentokil Initial PLC — the first driven by investor sentiment, the second by accounting standards. Rentokil Initial's market capitalization is 16.63 B. A P/B ratio of 2.98 indicates the market values Rentokil Initial above its accounting book value. Enterprise value stands at 20.35 B. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for Rentokil Initial are related but not identical, and they can diverge across cycles. For Rentokil Initial, key inputs include a P/E ratio of 38.73, a P/B ratio of 2.98, a profit margin of 6.8%, and ROE of 5.19%. By contrast, market price reflects the level where buyers and sellers transact.

What if' Analysis

Running a what-if backtest on Rentokil Initial PLC gives investors a practical way to test how changes in horizon, position size, or market timing might have affected the result. Used properly, this review helps investors decide whether Rentokil Initial's historical reward profile was stable enough to support the current thesis.
0.00
12/14/2025
 
No Change 0.00  0.0 
In 2 months and 31 days
 
03/14/2026
0.00
A  0.00  position in Rentokil Initial initiated on December 14, 2025 and held to today would record 0.00 in net gains. This reflects a 0.0% cumulative return in Rentokil Initial in total across 90 days. Rentokil Initial competes with or is related to UL Solutions, BIP Bermuda, Allegion PLC, Watsco, ITT, Textron, and Avery Dennison. This provides context for relative positioning. Rentokil Initial plc, together with its subsidiaries, provides route-based services in North America, the United Kingdom... More

Momentum Range Indicators for Rentokil Initial Snapshot

Upside/downside measures for Rentokil Initial frame directional pressure and range behavior. They provide a structured view of short-term momentum and range behavior.

Volatility and Risk Indicators for Rentokil Initial Snapshot

These indicators track Rentokil Initial's volatility and return range dynamics. The signals are informational and describe volatility patterns.
The degree to which Rentokil Initial's exhibits mean reversion depends on how efficiently the market prices new information. In highly covered equities, the mean reversion window tends to be shorter.
Hype
Prediction
LowEstimatedHigh
30.1732.4734.77
Details
Intrinsic
Valuation
LowRealHigh
29.1136.6138.91
Details
Naive
Forecast
LowNextHigh
31.0733.3735.67
Details
4 Analysts
Consensus
LowTargetHigh
32.5535.7739.70
Details
Before investing in Rentokil Initial, assess how Rentokil Initial's compares to its competitive peer group. A company that appears undervalued in absolute terms may be fairly priced when measured against sector-relative benchmarks.

Technical Indicators

Rentokil Initial PLC Backtested Returns

Rentokil Initial registers a very low volatility profile across the specified investment window. It records an Efficiency (Sharpe) Ratio of 0.0958, indicating risk-adjusted returns over the last 3 months. Volatility modeling revealed twenty-eight technical measures impacting risk exposure. Please evaluate metrics such as risk-adjusted performance of 0.0845, semi deviation of 1.87, and Coefficient Of Variation of 1018.82 to validate implied downside exposure. On a scale of 0 to 100, Rentokil Initial holds a performance score of 7. The company owns a Beta (Systematic Risk) of 0.34, which means possible diversification benefits within a given portfolio. As returns on the market increase, Rentokil Initial's returns are expected to increase less than the market. However, during a bear market, the loss from holding Rentokil Initial is expected to be smaller as well. Please confirm Rentokil Initial's relationship between the accumulation distribution and period momentum indicator, to make a quick decision on whether Rentokil Initial's historical returns will revert.
Auto-correlation
    
  -0.35  

Poor reverse predictability

Rentokil Initial PLC exhibits poor reverse predictability. Autocorrelation measures the degree of predictability between Rentokil Initial time series from 14th of December 2025 to 28th of January 2026 and from 28th of January 2026 to 14th of March 2026. Persistent correlation between intervals suggests underlying momentum patterns in Rentokil Initial that may carry forward. The measured coefficient of -0.35 means nearly 35.0% of Rentokil Initial's recent price variance traces back to prior period behavior. Given that Rentokil Initial PLC has negative autocorrelation for the selected time horizon, market participants may evaluate potential contrarian price behavior over comparable future intervals.
Correlation Coefficient-0.35
Spearman Rank Test-0.46
Residual Average0.0
Price Variance0.83
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Rentokil Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

-3.33 Billion
Accumulated Other Comprehensive Income is evolving in line with broader financial reporting trends. Last year, Rentokil Initial recorded Accumulated Other Comprehensive Income of -3.17 Billion.
Based on the recorded statements, Rentokil Initial PLC reported net income of 215.73 M. This is 16.85% lower than that of the Commercial Services & Supplies sector and significantly higher than that of the Industrials industry. The net income for all United States stocks is 62.22% higher than that of the company.

Rentokil Net Income Peer Comparison

Stock peer comparison using Net Income is a reliable method for evaluating Rentokil Initial against comparable stocks. Investors use Rentokil Initial's Net Income relative to peers to identify whether the stock is attractively or expensively valued.
Rentokil Initial is currently under evaluation in net income compared to key competitors.

Rentokil Initial ESG Sustainability

Companies with high ESG scores, including Rentokil Initial, often attract premium market valuations. Although Rentokil Initial's ESG disclosures are largely voluntary, they offer investors a meaningful view of the company's governance practices and long-term commitments.
Environmental
Governance
Social

Rentokil Initial Institutional Holders

The institutional investor base for Rentokil Initial comprises large financial entities such as pension funds, endowments, and investment managers that hold Rentokil Initial's shares. Because of the size of their positions, institutional investors can meaningfully influence Rentokil Initial's.
Shares
Summitry Llc2025-12-31
1.5 M
Optiver Holding B.v.2025-09-30
1.5 M
Bank Of America Corp2025-09-30
1.5 M
The Goldman Sachs Group Inc2025-09-30
1.4 M
Jpmorgan Chase & Co2025-09-30
1.1 M
Morgan Stanley - Brokerage Accounts2025-09-30
1.1 M
Nichols & Pratt Advisers Llp2025-12-31
997.1 K
Harvey Partners Llc2025-12-31
886.2 K
Bank Of Montreal2025-09-30
854.5 K
Hhg Plc2025-09-30
16.2 M
Gates Capital Management Inc2025-09-30
M

Rentokil Fundamentals

Financial Metrics, Fundamentals & Methodology

Rentokil Initial reports annual revenue of 5.14 B, a profit margin of 6.8%, ROE of 5.19%, debt-to-equity of 2.64. Fundamental metrics for Rentokil Initial center around operating performance and capital allocation discipline. Cash reserves enhance macroeconomic adaptability. Rentokil Initial financial statements indicate revenue of 5.14 B, positive EPS of 0.57, operating margin of 4.74%, current ratio of 1.88.

Unless otherwise specified, data for Rentokil Initial PLC is compiled from periodic company reporting and market reference feeds and standardized for comparability. Analyst inputs may be included when coverage is available. Updates may occur throughout the day. Financial statement fields are presented under issuer-reported GAAP or IFRS accounting conventions.

This content is curated and reviewed by:

Gabriel Shpitalnik - Member of Macroaxis Editorial Board

Pair Trading with Rentokil Initial

Pair trading with Rentokil Initial can help investors hedge some company-specific exposure by balancing a long view with an offsetting position. The key question is whether the second leg adds real hedge value instead of just creating a more complex version of the same risk.

Moving together with Rentokil Stock

  0.620LHR Tyson Foods ClPairCorr

Moving against Rentokil Stock

  0.36TMIP Taylor MaritimePairCorr
  0.330IFX Electronic ArtsPairCorr
  0.3236E GFL ENVIRONM(SUBVTSHPairCorr
The information in the correlation table below can inform Rentokil Initial tax-loss harvesting decisions, showing which instruments historically move in lockstep with Rentokil Initial PLC and can serve as viable temporary replacements.
Negative correlation assets provide natural hedges against Rentokil Initial positions. When Rentokil Initial PLC's value declines, a negatively correlated instrument tends to rise, partially offsetting portfolio losses.
Pair evaluation and Correlation analysis for Rentokil Initial provide hedging context. This approach is commonly reviewed within sectors and across broader groups.
Pair CorrelationCorrelation Matching

More Resources for Rentokil Stock Analysis

A structured review of Rentokil Initial PLC often starts with core financial statements and trend context. Key ratios help frame profitability, efficiency, and growth context for Rentokil Initial PLC Stock. Highlighted below are reports that provide context for Rentokil Initial PLC Stock:
Analysis related to Rentokil Initial should be read together with other portfolio and risk tools before capital is reallocated. That is especially important when the goal is to improve the overall mix of instruments already held. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
 Quarterly Earnings Growth
0.883
 Dividend Share
0.124
 Earnings Share
0.57
 Revenue Per Share
13.685
 Quarterly Revenue Growth
-0.04
Market capitalization and book value offer complementary views of Rentokil Initial PLC — the first driven by investor sentiment, the second by accounting standards. Rentokil Initial's market capitalization is 16.63 B. A P/B ratio of 2.98 indicates the market values Rentokil Initial above its accounting book value. Enterprise value stands at 20.35 B. Intrinsic value represents an estimate of underlying worth and can differ from both market price and book value. Valuation methods compare these perspectives to frame context.
Value and price for Rentokil Initial are related but not identical, and they can diverge across cycles. For Rentokil Initial, key inputs include a P/E ratio of 38.73, a P/B ratio of 2.98, a profit margin of 6.8%, and ROE of 5.19%. By contrast, market price reflects the level where buyers and sellers transact.